𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Medico-Legal Aspects of Using Tissue Plasminogen Activator in Acute Ischemic Stroke

✍ Scribed by Nhu T. Bruce; William P. Neil; Justin A. Zivin


Publisher
Springer
Year
2011
Tongue
English
Weight
109 KB
Volume
13
Category
Article
ISSN
1092-8464

No coin nor oath required. For personal study only.

✦ Synopsis


Opinion statement

Intravenous alteplase or tissue plasminogen activator (tPA) has been the standard of care with proven efficacy for acute ischemic stroke for over a decade. Despite this, only a small fraction of potentially eligible stroke patients receive this medication. There seems to be a fear among practitioners of legal repercussions as a result of an increased risk of intracerebral hemorrhage due to tPA. This review of legal cases involving tPA will show that instead, physicians are often found liable as a result of not treating with tPA.


πŸ“œ SIMILAR VOLUMES